Trade Summary

3 days ago, LIN SUE-JEAN, serving as Dir at Arcutis Biotherapeutics, Inc. (ARQT), sold 4,946 shares at $24.38 per share, for a total transaction value of $120,586.94. Following this transaction, LIN SUE-JEAN now holds 27,567 shares of ARQT.

This sale represents a 15.21% decrease in LIN SUE-JEAN's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Monday, June 15, 2026 and publicly disclosed via SEC Form 4 filing on Thursday, June 18, 2026 (accepted Jun 17, 8:47 PM ET), 3 days after the trade was made.

Arcutis Biotherapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.